文献速递呼吸危重症与机械通气

ARDS 早期 RALE 评分变化与生存相关

Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS.
PubMed 文献 · Chest · 2020-07-10

基于 LIVE 试验三中心患者数据,对基线及第2或3天胸片行 RALE 评分,由两名独立评审者完成。结果显示基线 RALE 每增1分与90天死亡风险升高相关,RALE 随时间下降亦与90天死亡相关,校正年龄、性别、BMI 等变量后仍独立相关。

要点

  • 基线 RALE 每增1分,90天死亡风险升高(HR 1.04)。
  • RALE 随时间每单位时间降1分,也与90天死亡相关(HR 0.99)。
  • 早期 RALE 变化或可作为 ARDS 临床试验的替代终点。

核心结论

  • ARDS 发病后最初数天内 RALE 评分的变化与生存独立相关。
  • RALE 变化可能作为未来 ARDS 新疗法临床试验的替代终点。

研究设计与样本

  • 基于 LIVE 试验三个中心入组患者的数据。
  • 使用基线(第0天)及第2或3天可获得的胸部X线片。
  • RALE 评分由两名独立评审者完成。
  • 主要终点为90天死亡,采用边际 Cox 生存模型分析。

主要发现

  • 第0、2、3天分别对135、64、88张胸片进行 RALE 评分。
  • 基线 RALE 每增1分,90天死亡 HR 1.04(95%CI 1.01-1.08,P=.006)。
  • RALE 随时间每单位时间降1分,HR 0.99(95%CI 0.99-0.99,P=.03)。
  • 校正年龄、性别、BMI、SAPS II、升压药使用及入组后总液体量后仍相关。

关键数值与推荐

  • 基线 RALE 每增1分:HR 1.04(95%CI 1.01-1.08,P=.006)。
  • RALE 每单位时间降1分:HR 0.99(95%CI 0.99-0.99,P=.03)。

临床怎么用

  • 对 ARDS 患者可连续评估 RALE 评分以辅助判断预后。
  • RALE 早期变化可作为临床试验中评估疗效的候选替代终点。

局限性

  • 数据来自三个中心,样本量及外推性有限。
  • 仅纳入基线及第2或3天有胸片者,可能存在选择偏倚。
  • RALE 由两名评审者评分,未报告评分者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Radiographic Assessment of Lung Edema (RALE) score is associated with the severity of ARDS, and treatments targeted at reducing pulmonary edema such as conservative fluid management cause a reduction in RALE score over time. RESEARCH QUESTION: Are early changes in RALE score over time associated with survival in patients with ARDS? STUDY DESIGN AND METHODS: Data from patients enrolled in three centers in the Lung Imaging for Ventilation sEtting in ARDS (LIVE) trial with available chest radiographs at baseline (day 0) and days 2 or 3 were used. The RALE was scored by two independent reviewers. The primary end point was death by day 90, considering RALE score both at baseline and as a time-varying covariate in a marginal Cox survival model. RESULTS: RALE was scored from 135, 64, and 88 radiographs on days 0, 2, and 3, respectively. Both baseline RALE (hazard ratio [HR] for each one-point increment, 1.04; 95% CI, 1.01-1.08; P = .006) and the change in RALE over time (HR for each one-point decrease per unit of time, 0.99; 95% CI, 0.99-0.99; P = .03) were associated with death by day 90, even after adjustment for age, sex, BMI, Simplified Acute Physiology Score II, vasopressor use, and total volume of fluids received since study entry. INTERPRETATION: The change in RALE during the first days after ARDS onset is independently associated with survival and may be useful as a surrogate end point in future clinical trials of new therapeutics in ARDS.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jabaudon M, Audard J, Pereira B, et al. Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS. Chest. 2020. PMID: 32659235. doi:10.1016/j.chest.2020.06.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。